Retzius sparing prostatectomy: a quick guide

Written in association with: Mr Wissam Abou-Chedid
Published:
Edited by: Aoife Maguire

A Retzius-sparing prostatectomy is a surgical technique aimed at removing the prostate gland while preserving the Retzius space, a potential space between the bladder and the pelvic floor. This approach seeks to minimise damage to surrounding structures, potentially reducing postoperative complications such as urinary incontinence and sexual dysfunction.

 

Distinguished consultant urological surgeon Mr Wissam Abou-Chedid discusses the surgery, including its potential benefits and the ideal candidate for the surgery.

 

 

What is a Retzius-sparing prostatectomy?

 

Retzius-sparing prostatectomy is a surgical technique used to remove the prostate gland while preserving the Retzius space which is a virtual space between the bladder and the pubic bone. This technique involves making small incisions in the abdomen, through which specialised surgical instruments and a camera attached to robotic arms are inserted. The surgical robot assists the surgeon in delicately removing the prostate gland while avoiding damage to surrounding structures.

 

The Retzius-sparing prostatectomy technique allows meticulous dissection and removal of the prostate gland while sparing surrounding anatomical structures to minimise postoperative complications such as urinary incontinence and erectile dysfunction.

 

What are the potential benefits of Retzius-sparing prostatectomy?

 

Recovery of urinary function: Compared to traditional radical prostatectomy, Retzius-sparing prostatectomy offers a lower risk of urinary incontinence. This is because the technique aims to minimise damage to the muscles and nerves controlling bladder function, resulting in better post-surgery urinary continence. Patients undergoing this procedure may regain urinary continence more quickly than those undergoing traditional surgery.

 

Erectile dysfunction: Retzius-sparing prostatectomy also aims to preserve erectile function by reducing nerve damage during surgery. Studies have shown that patients who undergo this technique have better preservation of erectile function compared to those undergoing traditional prostatectomy.

 

Penile shortening: Retzius-sparing prostatectomy has been associated with a reduced risk of penile shortening compared to traditional methods, which can impact sexual function and quality of life.

 

Inguinal hernia: There is a lower risk of developing inguinal hernia after Retzius-sparing prostatectomy, which can occur due to weakening of the abdominal wall during surgery.

 

Peyronie's disease: Retzius-sparing prostatectomy is also associated with a reduced risk of Peyronie's disease, a condition characterised by the development of fibrous scar tissue inside the penis, which can cause curvature, pain, and erectile dysfunction.

 

Oncological drawbacks and effectiveness in removing cancerous tissue

 

There are no significant oncological drawbacks to the Retzius-sparing approach. Studies indicate that the technique is as effective as traditional methods in removing cancerous tissue.

 

Research comparing the two methods has found that when the surgery is performed by an expert surgeon with extensive expertise in this technique, there is no increase in the risk of positive surgical margins, indicating that cancer removal is comparable between the two approaches.

 

Technical challenges and candidacy for Retzius-sparing procedure

 

The Retzius-sparing procedure is more technically challenging for surgeons to perform compared to traditional methods. It requires specialised surgical skills and expertise due to its complexity.

 

It should be noted that not all patients may be suitable candidates for this surgery. Patients with larger prostates or more advanced cancer may not be ideal candidates for Retzius-sparing prostatectomy due to the increased surgical difficulty. Additionally, suitability for this procedure should be assessed on an individual basis by a qualified surgeon.

 

Long-term data on patient outcomes

 

While promising short-term results have been reported, there is limited long-term data comparing the Retzius-sparing method to traditional methods in terms of patient outcomes. Long-term studies are needed to fully assess the safety and efficacy of Retzius-sparing prostatectomy.

 

How many of Retzius-sparing prostatectomies have you performed?

 

In the last two years, I've successfully completed over 300 robotic-assisted Retzius-sparing radical prostatectomies.  This significant number places my patient cohort among the fastest-growing series for a single consultant in Europe for this surgical technique.

 

 

 

If you are contemplating a Retzius-sparing prostatectomy and would like to book a consultation with Mr Abou-Chedid, do not hesitate to do so by visiting his Top Doctors profile today.

By Mr Wissam Abou-Chedid
Urology

Mr Wissam Abou-Chedid earned his medical degree from the University of Saint Joseph in Beirut before completing his urology specialist training at Henry Mondor University Hospital in Paris. He further honed his skills through fellowships in minimally invasive and robotic surgery at Saint Augustin Clinic in Bordeaux and the Royal Surrey NHS Foundation Trust in Guildford.

He was then appointed as a consultant urological surgeon at the Royal Surrey NHS Foundation Trust in February 2022. His robust academic background, including multiple postgraduate diplomas in Andrology, Laparoscopic surgery, urodynamics and pelviperineology, a master's degree in biomedical sciences and a fellowship from the Royal College of Surgeons of Edinburgh, provides a solid foundation for his work.

Mr Wissam Abou-Chedid has distinguished himself as a leader in the field, particularly in robotic-assisted surgery and minimally invasive procedures for prostate cancer and benign prostatic enlargement. His exceptional track record is marked by his significant contribution to the volume of surgeries performed, with over 400 cases completed in the last two years alone, making him one of the highest-volume consultants for robotic prostate surgery in the UK during that period.

Beyond sheer volume, Mr Abou-Chedid's expertise extends to specialised techniques, notably in retzius sparing prostatectomy, where he is recognised as one of the highest-volume surgeons in Europe. This recognition underscores his proficiency in advanced surgical methods that prioritize patient outcomes and quality of life. In addition to his clinical practice, Mr Abou-Chedid serves as a robotic and minimal invasive urological surgery trainer at IRCAD, a renowned international center for research and training in minimally invasive surgery.

Here, he shares his extensive knowledge and skills with surgeons from around the world, emphasizing the importance of adopting the latest technologies and techniques to achieve optimal patient outcomes. Mr Abou-Chedid's commitment to innovation is evident in his pioneering work, such as day case robotic prostatectomy and the concept of self-removal of catheters post-prostatectomy. These groundbreaking advancements not only demonstrate his dedication to pushing the frontiers of urological surgery but also highlight his focus on improving patient recovery and quality of life.

Mr Wissam Abou-Chedid is not only dedicated to advancing prostate cancer care but also continually seeks new and modern techniques for the treatment of benign enlargement of the prostate, aiming to improve the quality of life for men experiencing urinary symptoms. Recognizing the importance of staying at the forefront of medical technology, he has championed the use of innovative treatments such as Rezum, Echolaser, Optilume, and Exime, among other cutting-edge technologies. By integrating these advanced methods into his practice, Mr. Abou-Chedid ensures that his patients have access to the most effective and minimally invasive treatments available.

His proactive approach to embracing new technologies underscores his commitment to delivering the highest standard of care and improving outcomes for men with urological conditions. Outside of his professional pursuits, Mr. Abou-Chedid is deeply involved in community outreach programs aimed at raising awareness about prostate cancer screening and prevention. Through these initiatives, he seeks to empower individuals to take charge of their health and advocate for early detection and intervention.

Mr Abou-Chedid's commitment to these causes extends to his active involvement with charities such as Prostate Cancer UK and The Prostate Project. He serves as a Prostate Cancer UK National Clinical Champion, leveraging his expertise to support the organization's mission of providing vital services, raising awareness, and funding research.

View Profile

Overall assessment of their patients


  • Related procedures
  • Sexually transmitted infections (STIs)
    Vaginoplasty
    Penis Enlargement (Phalloplasty)
    Adult circumcision
    Laparoscopy
    Urologic Oncology
    Geriatric Urology
    Kidney transplantation
    Phimosis
    Short frenulum
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.